• ASCO 2011 Update - Emerging Trends in Sarcoma Management
  • CME

  • ASCO 2011 Update - Emerging Trends in Sarcoma Management

  • Author(s)/Faculty: Scott H. Okuno, MD
    Source: HemOnc Today
    Type: Multimedia Articles/Items: 1
    Release Date: 7/27/2011 Expiration Date: 7/26/2012
    Credit Type: CME Number of Credit(s): 0.25
    Cost: Free Provider: Vindico Medical Education
  • Metastatic sarcoma describes a range of disease that have poor prognosis and limited options for treatment. For most patients, the available medications have significant toxicity, and even for patients who can tolerate treatment, disease progression usually occurs after 6 or 7 cycles of therapy. In this program, leading clinicians discuss how to balance drug toxicity with patient quality of life and maintaining survival, the role of surgery, and the impact on new medications that target the mTOR pathway and in clinical trials, including the SUCCEED trial, have demonstrated improved progression-free survival with a lower rate of adverse events than traditional chemotherapy.

Sponsorship Statement:
This continuing education activity is sponsored by

Support Statement:
This activity is supported by an educational grant from

Target Audience:
The intended audience for the activities is medical oncologists, surgical oncologists, hematologists/oncologists, oncology nurses, and other healthcare professionals involved in the treatment of patients with sarcoma.

Learning Objectives:
At the conclusion of this activity participants should be able to:

  • Discuss the paradigm shift involving endpoint analysis for sarcoma therapeutic clinical trials
  • Explain the efficacy of extending chemotherapy in the treatment of high-risk Gastrointestinal Stromal Tumors (GIST)
  • Analyze key findings from the SUCCEED Trial which studied the use of mTOR (mammalian Target Of Rapamycin) inhibitors in the treatment of sarcoma

Course Chair:
Scott H. Okuno, MD
Professor of Oncology
Mayo Clinic
Rochester, MN

External Reviewer:
Ronald A. Codario, MD, FACP (Employee of Vindico Medical Education)

Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Credit Designation
Vindico Medical Education designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, July 27, 2011 to July 26, 2012.

How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, watch and listen to the presentation, complete the posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 3 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)TM certificate.

Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page and the next page.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Planning Committee and Faculty members report the following relationship(s):
Scott H. Okuno, MD
No relevant financial relationships to disclose.

External Reviewer reports the following relationship(s):
Ronald A. Codario, MD, FACP (Employee of Vindico Medical Education)
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2011 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.